Puma Biotechnology Inc - Company Profile
Powered by
All the data and insights you need on Puma Biotechnology Inc in one report.
- Save hours of research time and resources with
our up-to-date Puma Biotechnology Inc Strategy Report
- Understand Puma Biotechnology Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Puma Biotechnology Inc (Puma) is a clinical stage biopharmaceutical company that focuses on development and commercialization of cancer care products. Neratinib based pipeline and its research and development focus, increased net working capital are its strengths, even as history of increasing trade receivables could be a major cause of concern. The company could benefit from the growing incidence of cancer, product capabilities and rising healthcare expenditure cost. However, high competition, stringent regulations, and dependence on third party manufacturers could impact the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer